Active, Not Recruiting
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2
NCT06952530
- Conditions
- Cardiovascular Diseases, Hypertension, Vascular Diseases
- Locations
-
- Elite Clinical Studies, LLC Phoenix, Arizona, United States
- Valley Clinical Trials, Inc. Covina, California, United States
- Valley Clinical Trials, Inc. Northridge, California, United States
- Chase Medical Research, LLC Waterbury, Connecticut, United States